Drug Type Live biotherapeutic products |
Synonyms |
Target- |
Action modulators |
Mechanism Bacteria replacements, Gastrointestinal microbiome modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Congenital Ichthyosiform Erythroderma | Preclinical | United States | 16 Mar 2021 | |
Rosacea | Preclinical | United States | - |